Company Name: Acorda Therapeutics, Inc.

Acorda Therapeutics, Inc. is engaged in the development of therapies for neurological disorders.  The company markets FDA-approved therapies and has a developmental pipeline that includes product candidates for a variety of neurological conditions including:

  • Parkinson’s disease
  • Post-stroke walking difficulties
  • Migraine
  • Multiple sclerosis

Ticker Symbol: ACOR (NASDAQ)

Company Website: www.acorda.com

Social Media:

Acorda Therapeutics Facebook

Acorda Therapeutics Instagram

Acorda Therapeutics LinkedIn

Acorda Therapeutics Twitter

Headquarters: Ardsley, NY